THC · Tenet Healthcare Corporation New · Stock research

OSCR

Oscar Health, Inc.

Margin-recovery re-rate has carried the ACA pure-play leader to new highs, clearing the $30.38 prior 52-wk high on the +11% July 1 break with managed-care breadth (CNC/MOH/AGL) accelerating. But at $30.54 it trades ~28% above the $23.8 consensus target into the Aug 6 Q2 binary — a late-leg continuation, not a pre-consensus entry.

ARCB

ArcBest Corporation

LTL-recovery narrative is maturing and now fighting a company crack: ArcBest's July 16 restructuring — 2% headcount cut, $76.5M impairment, brand simplification — signals the freight-cycle upturn hasn't reached its own P&L, with the July 29 Q2 print the binary that resolves self-help vs demand miss.

CNC

Centene Corporation

Managed-care recovery off the 2025 ACA blowup is largely priced (+137% off $25.08 into the low-$60s). The ~2026-07-28 Q2 print is a binary into a hostile tape — Molina sank 12% on 2026-07-23 despite an EPS beat, Elevance's soft guide triggered a sector selloff. Theme MATURING→SATURATED; strength is being sold, not chased.

HUM

Humana Inc.

Medicare Advantage margin-recovery re-rate; the 2027 CMS +2.48% rate print doubled HUM off $163, but the discovery catalyst is spent and price ~$382 sits above the $304 average target. The ~2026-07-30 Q2 print is now the binary inside the window — a chase at all-time highs, not a fresh setup.